-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Haemonetics, Lowers Price Target to $62

Benzinga·05/08/2026 18:32:45
Listen to the news
JP Morgan analyst Allen Gong maintains Haemonetics (NYSE:HAE) with a Neutral and lowers the price target from $74 to $62.